- From: Alex Puig <alex@caelumlabs.com>
- Date: Wed, 8 Apr 2020 06:34:46 +0200
- To: "D.W.Chadwick" <info@verifiablecredentials.info>
- Cc: Adrian Gropper <agropper@healthurl.com>, Moses Ma <moses.ma@futurelabconsulting.com>, Christopher Allen <ChristopherA@lifewithalacrity.com>, Credentials Community Group <public-credentials@w3.org>
- Message-ID: <CAHdUGAFtt9r2WUMCJokJd5P=bcptn8jwPs5Qx6oy1_R-JAgynQ@mail.gmail.com>
For now, a VC example in JSON would do the job. Anyway, we are working with a well known epidemiologist, who can help us on this. Alex El mié., 8 abr. 2020 a las 6:32, D.W.Chadwick (< info@verifiablecredentials.info>) escribió: > Hi Alex > > do you want a VC example in JSON, or a signed example using JWT? These > are the only ones I have. If you want a ZKP or JSON-LD signed one you > will need to ask someone else. > > Note that the example we are using is not a medically correct one, but > rather is a template that will need to be completed with medical details > once these have been standardised. Perhaps Adrian might be able to fill > in more details? > > kind regards > > David > > On 08/04/2020 15:58, Alex Puig wrote: > > This is relevant to me. > > > > We are working on an implementation of > > https://github.com/DP-3T/documents using Zenroom. > > > > An immunity credential example would help us. > > > > Alex > > > > El mar., 7 abr. 2020 a las 23:27, Adrian Gropper > > (<agropper@healthurl.com <mailto:agropper@healthurl.com>>) escribió: > > > > HT to Juan C. > > https://unherd.com/2020/04/how-far-away-are-immunity-passports/ > > > > I would ask: IWhat is the role of VC relative to local or > > decentralized governance to solving this issue? > > > > - Adrian > > > > > > On Tue, Apr 7, 2020 at 3:10 PM D.W.Chadwick > > <info@verifiablecredentials.info > > <mailto:info@verifiablecredentials.info>> wrote: > > > > Hi Moses > > > > over the last week or so we have developed a proof of concept > > COVID-19 > > Immunity Certificate application demonstrator built on our > > application > > independent verifiable credential middleware. We would like to > > participate in challenge (1) headed by Victoriano. I am > > currently in the > > process of making a video of our demo > > > > Kind regards > > > > David > > > > On 08/04/2020 06:51, Moses Ma wrote: > > > Hi Christopher et al, > > > > > > You're absolutely right. This is why we have recruited: Dr. Ab > > > Osterhaus to join our team - he is one of the world's > > leading experts > > > in coronaviruses, and his team was first to sequence the > > SARS virus, > > > Dr. Tony Cox - a data scientist who specializes in > > epidemiology, and > > > Triall.io - a clinical research organization that has run > > over 30 > > > Phase I-IV trials and is the developer of the first > > blockchain tool > > > for clinical trials. All of our proposed pilots will adhere to > > > clinical research methodologies that preserve patient > > privacy and > > > insure validated data production. > > > > > > However, what we could use more of are privacy experts who > > can quickly > > > produce innovative working solutions. > > > > > > Two challenges we've identified are: (1) the use of verifiable > > > credentials to serve as digital certificates of immunity, > > and (2) the > > > possibility of developing interoperable contact managers and > > globally > > > unique IDs to enable international travel. A big thanks to > > Victoriano > > > Giralt for stepping up to manage the first one, but I think > > we still > > > need to find a MacGyvered approach to solving the second... > > in a way > > > that has a low barrier to federation and adoption. To be > > brutally > > > honest, we are triaging a solution, and we need to see > > reality clearly > > > as to whether DIDs can add value short term. > > > > > > If you'd like to work on these sub-projects, please let me > > know. > > > Again, this is an action-primary team that will need to deliver > > > software on an super-agile basis. > > > > > > Anyway, I promised to share the recording of our first call > > so you > > > know what we're up to, and you can find it here: > > > > > > https://www.dropbox.com/s/rqhpum88k28usti/Zoom-DefenderDIDcall-040620.mp4?dl=0 > > > > > > Finally, I'll try to make time for CCG calls, but I'm getting > > > exponentially busier these days. > > > > > > > > > Stay healthy everyone! > > > > > > Moses > > > > > > > > > PS, thisis a very interesting article about user acceptance > > of contact > > > managers:https://045.medsci.ox.ac.uk/user-acceptance - > > respondents > > > were most concerned about “government using the app as an > > excuse to > > > increase surveillance after the epidemic”. > > > > > > > > > <https://045.medsci.ox.ac.uk/user-acceptance> > > > > > > On 4/7/20 10:19 AM, Christopher Allen wrote: > > >> As was discussed briefly in the call today, if we are going > > to talk > > >> about #Covid19 technology solutions, we must partner with > > health & > > >> epidemiological experts to do it right. > > >> > > >> For instance, it has been proposed that we support some > > kind of > > >> digital immunity certificate. Even if we ignore its possible > > >> human-rights & privacy risks, it can have still have risky > > public > > >> health care choices: > > >> > > >> > https://unherd.com/2020/04/how-far-away-are-immunity-passports/ > > >> > > >> “If you issue immunity passports on this basis, /barely a > > third /of > > >> the people you give them to will actually be immune. > > “There’s nothing > > >> peculiar about this statistically,” Kevin McConway, an > > emeritus > > >> professor of statistics at the Open University, told me. > > “It’s just > > >> Bayes’ theorem > > <https://en.wikipedia.org/wiki/Bayes%27_theorem>.” The > > >> likelihood of you having had Covid-19, if you’ve had a > > positive test, > > >> depends not just on the accuracy of the test but on the > > prevalence in > > >> the population you’re looking at. > > >> … > > >> In the end, that’s going to be a horribly cold-blooded > > calculation. > > >> If you let people out when they’re 90% likely to be immune, > > that > > >> means one person in 10 is going to be at risk of getting and > > >> spreading the disease. Is that risk a price worth paying > > for reducing > > >> the real costs (economic, social, physical, mental) of > > isolation? I > > >> don’t know and I’m glad I don’t have to work it out. But > > someone has > > >> to. And they’ll have to start by getting a reasonably > > effective test, > > >> and testing hundreds of thousands of people, to see how > > many of us > > >> have had it.” > > >> > > >> — Christopher Allen > > > > > > > > > -- > > > > > > *Moses Ma | Managing Partner* > > > > > > moses.ma@futurelabconsulting.com > > <mailto:moses.ma@futurelabconsulting.com> | moses@ngenven.com > > <mailto:moses@ngenven.com> > > > > > > v+1.415.568.1068 | skype mosesma | /linktr.ee/moses.tao/ > > <http://linktr.ee/moses.tao/> > > > <http://linktr.ee/moses.tao> > > > > > > FutureLab provides strategy, ideation and technology for > > breakthrough > > > innovation and third generation blockchains. > > > > > > Learn more at /www.futurelabconsulting.com/ > > <http://www.futurelabconsulting.com/> > > > <http://futurelabconsulting.com>. For calendar invites, > > please cc: > > > mosesma@gmail.com <mailto:mosesma@gmail.com> > > > > > > > > > Or whet your appetite by reading /Agile Innovation/ > > > > > < > http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A > > > > > > > | /Quantum Design Sprint/ > > > > > < > https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864 > > > > > > > | my blog at /psychologytoday.com/ > > <http://psychologytoday.com/> > > > <http://www.psychologytoday.com/blog/the-tao-innovation>. > > > > > > NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE INTENDED > > > RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS E-MAIL > > IN ERROR, > > > ANY REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR COPYING OF > > THIS > > > E-MAIL IS STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER > > IMMEDIATELY OF > > > THE ERROR BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE > > FROM YOUR > > > SYSTEM. THIS EMAIL SHOULD NOT BE CONSIDERED BINDING; HARD COPY > > > DOCUMENTS ARE REQUIRED TO CREATE LEGALLY BINDING > > COMMITMENTS. FOR > > > CALENDAR INVITES, PLEASE CC: MOSESMA@GMAIL.COM > > <mailto:MOSESMA@GMAIL.COM> > > > > > > > > > > > -- > > > > Alex Puig > > > > CTO > > > > +34 678544357 > > > > alex@caelumlabs.com <mailto:alex@caelumlabs.com> > > > > Follow us!Twitter <https://twitter.com/caelumlabs>| > > > > linkedin <https://www.linkedin.com/company/caelumlabs/>| Newsletter > > <http://newsletter.caelumlabs.com/>|Gitlab < > https://gitlab.com/caelumlabs> > > > > IMPORTANT: The contents of this email and any attachments are > > confidential. It is strictly forbidden to share any part of this > > message with any third party, without a written consent of the sender. > > If you received this message by mistake, please reply to this message > > and follow with its deletion, so that we can ensure such a mistake > > does not occur in the future. > > > > * > > > > * > -- Alex Puig CTO +34 678544357 alex@caelumlabs.com Follow us! Twitter <https://twitter.com/caelumlabs> | linkedin <https://www.linkedin.com/company/caelumlabs/> | Newsletter <http://newsletter.caelumlabs.com/> | Gitlab <https://gitlab.com/caelumlabs> IMPORTANT: The contents of this email and any attachments are confidential. It is strictly forbidden to share any part of this message with any third party, without a written consent of the sender. If you received this message by mistake, please reply to this message and follow with its deletion, so that we can ensure such a mistake does not occur in the future.
Received on Wednesday, 8 April 2020 04:35:31 UTC